<DOC>
	<DOCNO>NCT01762228</DOCNO>
	<brief_summary>This study evaluate videofluoroscopy ( radiologic method study deglutitive physiology ) effect deglutition two therapeutic treatment duration 2 week , base increase sensorial stimuli old patient oropharyngeal dysphagia : 1 . Stimulation Transient Receptor Potential Vanilloid 1 ( TRPV1 ) oropharynx chanels use natural agonist administrate alimentary bolus . 2 . Stimulation sensorial neuron pharynx larynx use transcutaneous electrical stimulus . Moreover , electroencephalographic study assess effect treatment cortical neuroplasticity .</brief_summary>
	<brief_title>Efficacy Two Interventions Increasing Sensory Stimulus Elderly Patients With Oropharyngeal Dysphagia</brief_title>
	<detailed_description>This study evaluate videofluoroscopy ( radiologic method study deglutitive physiology ) effect deglutition two therapeutic treatment duration 2 week , base increase sensorial stimuli old patient oropharyngeal dysphagia : 1 . Stimulation Transient Receptor Potential Vanilloid 1 ( TRPV1 ) oropharynx chanels use natural agonist administrate alimentary bolus . 2 . Stimulation sensorial neuron pharynx larynx use transcutaneous electrical stimulus . The study last 5 week per patient . At begin study , patient receive videofluoroscopic evaluation electroencephalography ( evoked potential ) asses dysphagia cortical activity deglutition . After first day third week begin treatment ( group b ) 2 week . Finally fifth week evaluation dysphagia perform way week 1 ass effect treatment .</detailed_description>
	<mesh_term>Deglutition Disorders</mesh_term>
	<criteria>Elderly patient ( â‰¥70 year ) oropharyngeal dysphagia ( OD ) Patients fill sign write informed consent . Patients without exclusion criterion . Patients able comply protocol . Patients currently participate participate another clinical trial last 4 week . Patients active neoplasia . Patients active infectious process . Patients severe dementia inability communicate . Patients pacemaker . Patients implanted electrode . Patients epilepsy convulsive disorder . Patients gastroesophageal reflux disease .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Oropharyngeal dysphagia</keyword>
	<keyword>Elderly</keyword>
	<keyword>Transcutaneous electrical stimulation</keyword>
	<keyword>TRPV1 agonist</keyword>
</DOC>